CCB Portal Please support MJHS Institute
Facebook Twitter YouTube LinkedIn

Interprofessional Webinar Series:
COPD, Dementia, and a Distressed Family

This webinar is presented in collaboration with the
National Hospice and Palliative Care Organization.

Funding Disclosure: No commercial funding has been accepted for the activity.

Date and Time: August 17, 2017, 12:30 PM – 1:30 PM ET (Live)

Location: Online at http://www.mjhspalliativeinstitute.org/e-learning/

Speaker Name and Title:
Russell K. Portenoy, MD
Executive Director, MJHS Institute for Innovation in Palliative Care
Chief Medical Officer, MJHS Hospice and Palliative Care
Professor of Neurology, Albert Einstein College of Medicine

Mara Lugassy, MD
Senior Hospice Medical Director 
MJHS Hospice and Palliative Care

Wanda Youdelman, RN, CHPN
Staff Development Manager
MJHS Hospice and Palliative Care

Linda Norris Stertz, LCSW-R
Social Work Manager
MJHS Hospice and Palliative Care

Rabbi Leonard Blank, MS, BCC
Rabbinic Liaison
MJHS Hospice and Palliative Care

Purpose: The purpose of this webinar is to describe the interdisciplinary assessment and management of a complex patient with advanced pulmonary disease and dementia, with a focus on the patient and family as the unit of care.

Objectives:
Participants will be able to:

  1. Describe the problem of multimorbidity in palliative care
  2. Perform a comprehensive assessment of the patient with two serious chronic illnesses, each in need of specific interventions to address the sources of distress and burden for the patient and family
  3. Counsel the families of patients with advanced dementia in the approach to manage the behavioral disturbances that occur with this disease
  4. Safely and effectively manage the pharmacological options that can improve confusion and agitation in a patient with dementia, and do so in a manner that minimizes the risk of adverse consequences related to medical comorbidity

Why Do I Need to Know This?
Patients with advanced illness commonly present with more than one serious illness, and the co-occurrence of dementia and COPD is common.  Dementia can occur with behavioral manifestations and functional decline, both of which are profoundly upsetting to the family.  The assessment and management by an interdisciplinary team of a patient with progressive dementia and severe COPD requires that the patient and family be viewed as the unit of care, and that the plan of care address medical, psychosocial, and spiritual sources of distress and burden.  Medical therapies that reduce agitation often are needed and must be managed in a manner that minimizes risks in the context of multiple diseases.

Target Audience:
palliative care specialists, pain specialists, primary care providers, nurse practitioners, registered nurses, advanced practice nurses, registered nurses with a specialty in palliative care/hospice, pharmacists, allied health professionals, fellows, residents, and medical students.

Criteria for Successful Completion:

    1. Attendance at entire session (mandatory for nurses and pharmacists)
    2. Submission of completed evaluation form (mandatory to receive CE/CME credit for MDs and nurses)
    3. Submission of completed Verification of Continuing Education Participation Form, Program Evaluation Form, and CE Validation Form (mandatory for pharmacists). Pharmacists must email all three forms to PalliativeInstitute@mjhs.org or fax forms to 212-649-5544 within 45 days of webinar date.

Continuing Education Credits: 1.0

Continuing Education Accreditation:

Physicians: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Hospice and Palliative Care Organization (NHPCO) and MJHS. NHPCO is accredited by the ACCME to provide continuing medical education for physicians.

NHPCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: NHPCO is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s (ANCC) Commission on Accreditation.

NHPCO designates this live activity for a maximum of 1.0 contact hour. Nurses should claim only the contact hours commensurate with the extent of their participation in the activity. Accredited status by ANCC refers only to continuing nursing education and does not imply endorsement of any commercial product discussed in conjunction with this activity.

Social Workers: MJHS Institute for Innovation in Palliative Care SW CPE is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #0242.

Fees: 
Individual: $25 (includes CME/CE certificate)
Group: $95 + $5 per CME/CE certificate

Registration fees for webinars are not refundable.

System Requirements for Computers and Mobile Devices:
http://support.citrixonline.com/en_US/Webinar/help_files/G2W010003

Disclosures:
Russell K. Portenoy, MD, Planner, has indicated a relationship with AstraZeneca Pharmaceuticals LP for research support.

Mara Lugassy, MD, Linda Norris Stertz, LCSW-R, Wanda Youdelman, RN, CHPN, and Rabbi Leonard Blank have no financial arrangements or affiliations with any commercial entities whose products, research or services may be discussed in these materials. Any discussion of investigational or unlabeled uses of a product will be identified.

No other Planning Committee Member has any disclosures.

Planning Committee Members
Barbara Bouton, MA, FT
Colleen Fleming-Damon, PhDc, APRN-BC, ACHPN-BC, C.T.
Steven R. Gardner, MPA, PAHM
Myra Glajchen, DSW
Jennifer Kennedy, RN, MA, BSN, CHC
Russell K. Portenoy, MD
Karen Richards, PhD, EdS
Judith A. Skretny